Nexstim Oyj
NXTMH.HE develops and sells advanced medical equipment and technology, primarily generating revenue through the sale of diagnostic and therapeutic devices.
Business. NXTMH.HE is a healthcare company operating in the Advanced Medical Equipment & Technology industry. The firm generates revenue through the sale of products, with key performance indicators including organic revenue growth, procedure volume, and gross margin. Headquarters and specific operating segment details are not provided in the available data. The company is primarily listed on the Nasdaq Helsinki exchange under the ticker NXTMH.HE.
Analyst recommendations
1 analysts · consensus BuyAt a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
NXTMH.HE is a healthcare company operating in the Advanced Medical Equipment & Technology industry. The firm generates revenue through the sale of products, with key performance indicators including organic revenue growth, procedure volume, and gross margin. Headquarters and specific operating segment details are not provided in the available data. The company is primarily listed on the Nasdaq Helsinki exchange under the ticker NXTMH.HE.
NXTMH.HE has a debt-to-equity ratio of 0.99, indicating a balanced capital structure with moderate leverage. The company's liquidity is assessed as medium, with a current ratio of 1.27, suggesting it can cover its short-term obligations but with limited buffer. Free cash flow is negative at -57,860 EUR, which may indicate reinvestment in the business or operational inefficiencies.
Profitability metrics show a return on equity of 13.71% and a return on assets of 4.35%, which are strong indicators of efficient use of equity and assets. The operating margin is 5.80%, and the net profit margin is 5.23%, both of which are in line with industry expectations for a company in the Advanced Medical Equipment & Technology sector.
The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification. This lack of diversification may expose the company to regional economic or regulatory risks.
Outlook data indicates a projected growth in revenue for the current fiscal year, with a positive delta expected. However, the next fiscal year's growth is uncertain, with no significant changes in revenue expected. Historical revenue growth has been steady, with a total revenue of 10,968,810 EUR in the latest reporting period.
Risk factors include a medium liquidity risk due to a current ratio of 1.27 and a negative net cash position after subtracting total debt. The dilution risk is assessed as low, with no significant dilution expected in the near term. No recent events or filings have been disclosed that would significantly impact the company's operations or financial position.
- NXTMH.HE maintains a balanced capital structure with a debt-to-equity ratio of 0.99.
- The company's profitability is strong, with a return on equity of 13.71%.
- Revenue is concentrated in a single business segment, which may increase risk exposure.
- Liquidity is assessed as medium, with a current ratio of 1.27.
- Free cash flow is negative, indicating potential reinvestment or operational inefficiencies.
- "margin_outlook_rationale": "Operating and net profit margins are stable, with no significant changes expected in the near term.",
Bull / Bear case
Generated · model-assistedIn focus — financials by report
Valuation
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
| Metric | Our forecast | Guidance | Consensus |
|---|---|---|---|
| EPS | —no estimate | —no estimate | 0,14 |
| Revenue | —no estimate | —no estimate | 13,0M EUR |
| Operating income | —no estimate | —no estimate | 1,0M EUR |
Options
Short squeeze
Earnings-call key lines
Consensus distribution
sell-side coverageEstimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Net Cashcash_and_equivalents + short_term_investments - short_term_debt - long_term_debt
- Capex To Revenuecapital_expenditure / revenue
- Return On Equitynet_income / total_equity
- Debt To Equity(short_term_debt + long_term_debt) / total_equity
- Cash Conversion Ratiooperating_cash_flow / net_income
- NXTMH.HE Market data — financials · 2026-05-28
- Nexstim Oyj Market data — analyst estimates · 2026-05-28